ProShares Ultra NASDAQ Biotechnology
BIB
BIB
37 hedge funds and large institutions have $16M invested in ProShares Ultra NASDAQ Biotechnology in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
71% less capital invested
Capital invested by funds: $54.6M → $16M (-$38.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
37
Holding in Top 10
–
Calls
$10.3M
Puts
$3.75M
Top Buyers
1 | +$2.36M | |
2 | +$1.23M | |
3 | +$596K | |
4 |
HF
HRT Financial
New York
|
+$536K |
5 |
Jane Street
New York
|
+$518K |
Top Sellers
1 | -$19.9M | |
2 | -$16.2M | |
3 | -$1.3M | |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.03M |
5 |
TFA
Toth Financial Advisory
Leesburg,
Virginia
|
-$910K |